Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sagopilone in Metastatic Breast Cancer
NCT00313248Phase 2Completed
- Sponsor
- Bayer
- Start
- Apr 2006
- Primary completion
- Oct 2008
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 2, open-label trial of sagopilone in breast cancer (2 arms), sponsored by Bayer. Primary endpoint: Objective Response Rate. Started Apr 2006; status: completed.
02
Drugs
sagopilone
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00313248.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00313248.